Global Inactivated Vaccines Market Size
Pharmaceuticals

Inactivated Vaccines Global Market Outlook 2024-2033: Size And Growth Rate Analysis

The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The inactivated vaccines market has witnessed a steady increase in size, showcasing its resilience and adaptability. In 2023, the market stood at $5.95 billion and is projected to reach $6.19 billion in 2024, with a Compound Annual Growth Rate (CAGR) of 4.2%. Looking ahead, the forecast for 2028 predicts further growth, reaching $7.33 billion at a CAGR of 4.3%. This evolution is attributed to various factors, including historic polio eradication efforts, influenza vaccination programs, and regulatory approvals. Let’s delve into the key drivers and trends shaping this upward trajectory.

Immunization Initiatives Driving Market Growth

  • Immunization Initiatives Overview
    • Organized efforts or campaigns to vaccinate individuals or communities.
    • Crucial for protection against infectious diseases.
  • Impact on Market Growth
    • Higher demand for inactivated vaccines due to increased vaccination efforts.
    • Stimulates market growth and fosters research and development investments.
  • Global Impact
    • According to the World Health Organization (WHO):
      • Vaccines prevent 4-5 million lives lost annually globally.
      • Around 84% of infants received three doses of the polio vaccine in 2022.
      • An estimated 84% of infants in OPV-using countries received the IPV first dose.
  • Driving Force
    • Increasing immunization initiatives propel the growth of the inactivated vaccines market.

View More On The Inactivated Vaccines Market Report 2023 – https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report

Innovative Advancements by Leading Companies

  • Introduction to Inactivated Vaccines
    • Contain inactivated virus particles, bacteria, or pathogens.
    • Developed in culture and subsequently killed to destroy disease-producing ability.
  • Case Study: GSK PLC
    • Released Shingrix in January 2022.
    • A non-live, recombinant subunit adjuvanted vaccination.
    • Administered intramuscularly in two doses.
    • Originally indicated for individuals 50 years and older, expanded to cover high-risk individuals aged 18 and older.
  • Market Dynamics
    • Major companies introduce innovative and advanced inactivated vaccines.
    • Sustain market position through ongoing research and development.

Collaboration Boosts COVID-19 Vaccine Production

  • Collaboration Overview
    • Albumedix Ltd. and Valneva SE collaboration in April 2022.
    • Aims to increase inactivated COVID-19 vaccine production capacity.
  • Valneva SE Profile
    • France-based biotech company.
    • Specializes in discovering, producing, and marketing inactivated vaccines for infectious illnesses.

Market Segmentation and Regional Trends

  • Market Segmentation
    • By Type: Viral Vaccine, Bacterial Vaccine.
    • By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods.
    • By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels.
  • Regional Trends
    • North America: Largest region in the inactivated vaccines market in 2023.
    • Asia-Pacific: Expected to be the fastest-growing region in the forecast period.

Request A Sample Of The Global Inactivated Vaccines Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=13018&type=smp

The Inactivated Vaccines Global Market Report 2023  provides a comprehensive overview on the inactivated vaccines market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Meningococcal Vaccines Global Market Report 2023
Typhoid Vi Polysaccharide Vaccine Global Market Report 2023
Pediatric Vaccine Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model